1-4 of 4
Bao Hoang, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.

Patrick J. Frost, PhD, YiJiang Shi, MD, Carolyne Bardalaban, PhD, Bao Hoang, PhD, Alan Lichtenstein, MD
Journal: Blood
Blood (2007) 110 (11): 4795.
https://doi.org/10.1182/blood.V110.11.4795.4795
Published: 2007
Journal Articles

AKT Kinase Addiction in Multiple Myeloma.

Carolyne Bardeleben, PhD, Huajun Yan, PhD, Patrick Frost, PhD, Bao Hoang, PhD, Yijiang Shi, MD, PhD, Sanjai Sharma, MD, Alan Lichtenstein, MD
Journal: Blood
Blood (2006) 108 (11): 3431.
https://doi.org/10.1182/blood.V108.11.3431.3431
Published: 2006
Journal Articles

Anti-Angiongenic Effects of mTOR-Inhibitors Is Regulated by AKT Activity in Multiple Myeloma Cells.

Patrick Frost, PhD, Bao Hoang, PhD, Yijiang Shi, MD, Huajun Yan, PhD, Alan Lichtenstein, MD
Journal: Blood
Blood (2005) 106 (11): 3406.
https://doi.org/10.1182/blood.V106.11.3406.3406
Published: 2005
Journal Articles

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Huajun Yan, PhD, Patrick Frost, PhD, Yijiang Shi, MD & PhD, Bao Hoang, PhD, Sanjai Sharma, MD, Myrna Fisher, Joseph Gera, PhD, Alan Lichtenstein, MD
Journal: Blood
Blood (2005) 106 (11): 1582.
https://doi.org/10.1182/blood.V106.11.1582.1582
Published: 2005